It seems entirely fitting that Veterans Day this year precedes the annual Society for Neuroscience (SfN) meeting here in Washington, DC. As a nation, we pause to honor the men and women who have served the United States in uniform. As people involved in research on brain disorders, including the more than 30,000 who will attend the SfN meeting, we pause to think about the special role we play.
NIMH was founded by President Harry Truman to address the needs of soldiers returning from WWII with “combat neurosis,” the syndrome we recognize today as post-traumatic stress disorder (PTSD). Nearly 65 years later, we continue to pursue biomarkers for prediction, preventive interventions following a traumatic event, and treatments.